Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02395302 · ClinicalTrials.gov registry record · NA

Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers (VLUs)

A NA study of Venous Leg Ulcer and Venous Ulcer, sponsored by Tactile Medical.

Completed
Registry status
NA
Development phase
28
Enrollment target
6
Study locations

NCT02395302 is a NA study of Venous Leg Ulcer and Venous Ulcer that has completed, run by Tactile Medical. The registered enrollment target is 28 participants, below the 244-participant average among 35 other Venous Leg Ulcer trials with a reported enrollment target (89% lower). The trial reports 6 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02395302, a NA study of Venous Leg Ulcer and Venous Ulcer, has completed, sponsored by Tactile Medical.

COMPLETED
Registry status
NA
Development phase
28 participants
Enrollment target
6
Study locations

Study Summary

The purpose of the study is to assess treatment tolerance and comfort in chronic VLUs after 4 weeks of treatment using a dual action pneumatic compression device.

Interventions

  • DEVICE Dual Action Pneumatic Compression

Study Locations (6)

Massachusetts

  • Tufts Medical Center - Boston
  • Boston Medical Center - Boston

California

  • Center for Clinical Research - San Francisco

Florida

  • University of Miami School Hospital - Miami

New Jersey

  • Englewood Hospital and Medical Center - Englewood

New York

  • St. Luke's Roosevelt Hospital Center - New York

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2014-12
Est. Completion 2015-11
Phase NA

Sponsor

Tactile Medical

14 total trials

What the Registry Record Tells You About NCT02395302

The ClinicalTrials.gov registry entry for NCT02395302 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 244-participant average among 35 other Venous Leg Ulcer trials with a reported enrollment target (89% lower). The listed sponsor is Tactile Medical, which has 14 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Venous Leg Ulcer appearing as the primary indexed condition, and to 1 intervention - of which Dual Action Pneumatic Compression is the first listed.

NCT02395302 reports 6 study locations spanning 5 distinct geographic areas - top geographies include Massachusetts, California, Florida.

Frequently Asked Questions

What is clinical trial NCT02395302 about?

NCT02395302 is a clinical study titled "Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers (VLUs)". The purpose of the study is to assess treatment tolerance and comfort in chronic VLUs after 4 weeks of treatment using a dual action pneumatic compression device.

What is the current status of trial NCT02395302?

This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2014-12. Estimated completion is 2015-11.

What conditions does trial NCT02395302 study?

This clinical trial studies the following conditions: Venous Leg Ulcer, Venous Ulcer, Venous Insufficiency, Venous Stasis Ulcer, Chronic Venous Insufficiency.

What interventions are being tested in trial NCT02395302?

The interventions under investigation include: Dual Action Pneumatic Compression (DEVICE).

Who is sponsoring clinical trial NCT02395302?

This trial is sponsored by Tactile Medical, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02395302 being conducted?

This trial has 6 study locations across California, Florida, Massachusetts, New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Venous Leg Ulcer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.